These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21190865)

  • 21. Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblings.
    Myers A; Lakey R; Cawston TE; Kay LJ; Walker DJ
    Rheumatology (Oxford); 2004 Mar; 43(3):272-6. PubMed ID: 14523226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum matrix metalloproteinase-3 in systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Arch Dermatol Res; 2004 Jun; 296(1):25-9. PubMed ID: 15095096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis.
    Ross EL; D'Cruz D; Morrow WJ
    J Rheumatol; 2000 Oct; 27(10):2432-43. PubMed ID: 11036841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
    Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
    Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis.
    Hofbauer LC; Schoppet M; Christ M; Teichmann J; Lange U
    Rheumatology (Oxford); 2006 Oct; 45(10):1218-22. PubMed ID: 16574701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
    O'Hara R; Murphy EP; Whitehead AS; FitzGerald O; Bresnihan B
    Arthritis Rheum; 2004 Jun; 50(6):1788-99. PubMed ID: 15188355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
    Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
    Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
    Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M
    J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
    Choe JY; Kim SK
    Inflamm Res; 2016 Jun; 65(6):479-88. PubMed ID: 26921306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cytokines in different histological variants of rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    J Rheumatol; 2001 Jun; 28(6):1211-7. PubMed ID: 11409111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble tumor necrosis factor-like weak inducer of apoptosis plasma levels as a novel biomarker of endothelial function in prevalent orthotopic heart transplant recipients.
    Przybylowski P; Malyszko JS; Malyszko J
    Transplant Proc; 2011 Jun; 43(5):1900-3. PubMed ID: 21693297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation.
    Stabler T; Piette JC; Chevalier X; Marini-Portugal A; Kraus VB
    Arthritis Rheum; 2004 Nov; 50(11):3663-7. PubMed ID: 15529362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.
    van Kuijk AW; Reinders-Blankert P; Smeets TJ; Dijkmans BA; Tak PP
    Ann Rheum Dis; 2006 Dec; 65(12):1551-7. PubMed ID: 16728461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of C-C chemokines and their receptors in osteoarthritis.
    Yuan GH; Masuko-Hongo K; Sakata M; Tsuruha J; Onuma H; Nakamura H; Aoki H; Kato T; Nishioka K
    Arthritis Rheum; 2001 May; 44(5):1056-70. PubMed ID: 11352237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble biomarkers may differentiate psoriasis from psoriatic arthritis.
    Chandran V
    J Rheumatol Suppl; 2012 Jul; 89():65-6. PubMed ID: 22751596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells. Beta-chemokine synthesis in corneal cells.
    Tran MT; Tellaetxe-Isusi M; Elner V; Strieter RM; Lausch RN; Oakes JE
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):987-96. PubMed ID: 8631642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
    Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
    J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.